Vote Scores

Home / Companies / Cartesian Therapeutics, Inc. / 20 Sep 2024

Meeting · year to 30 June 202551 filers reporting

Cartesian Therapeutics, Inc.: meeting of 20 Sep 2024

Votes reported on Form N-PX, item by item

51 Form N-PX filers reported votes at the Cartesian Therapeutics, Inc. meeting of 20 Sep 2024. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

89 vote records from 51 filers. 4 of the 49 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

88.2% for7.8% against3.9% other8.2% against management51 filers99.7% for0.3% against0.3% against management2,244,550 reported shares, counted once per item in this group
2

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

88 vote records from 50 filers. 5 of the 48 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

86.0% for10.0% against4.0% other10.4% against management50 filers99.7% for0.3% against0.3% against management1,984,539 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Cartesian Therapeutics, Inc. meeting?

51 Form N-PX filers reported votes at the meeting of 20 Sep 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Cartesian Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Cartesian Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Cartesian Therapeutics, Inc. with a meeting date within three days of 20 Sep 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.